SCHEDULE 13D/A: Major Shareholder Thomas J. Shaw Boosts Stake in Retractable Technologies to Over 53% Through 10b5-1 Plan

Thomas J. Shaw, a significant shareholder, has increased his beneficial ownership in Retractable Technologies Inc. to 53.3% through a Rule 10b5-1 trading plan, executing multiple purchases in early 2025.

Summary

• Thomas J. Shaw has increased his beneficial ownership in Retractable Technologies Inc. to 15,949,849 shares, representing 53.3% of the common stock.
• This increase is primarily due to purchases made under a Rule 10b5-1(c) trading plan, which was established on August 22, 2024.
• The plan's trading activity is stated to have begun on November 20, 2025, and is set to continue through November 19, 2025, unless terminated earlier (note: the start date appears to be a typographical error in the original document, as purchases are listed for January and February 2025).
• Recent open market purchases by Mr. Shaw's broker, as reported on Form 4, include various transactions in January and February 2025, with weighted average prices per share ranging from $0.682 to $0.812.
• Mr. Shaw holds sole voting power over 15,449,849 shares and sole dispositive power over 15,618,249 shares.
• Beneficiaries of two trusts have rights to dividends or proceeds from 331,600 shares and 500,000 shares beneficially owned by Mr. Shaw.

Sentiment

Score: 8

Explanation: The sentiment is positive due to significant insider buying by a major shareholder, indicating strong confidence and a controlling stake. This typically signals a belief in the company's undervaluation or strong future prospects.

Positives

• Significant insider buying by a major shareholder, Thomas J. Shaw, indicates strong confidence in the company's future prospects.
• The establishment of a Rule 10b5-1 plan provides a structured and pre-planned approach to increasing ownership, reducing concerns about opportunistic trading.
• Mr. Shaw's beneficial ownership now exceeds 50%, giving him a controlling stake and potentially aligning his interests more closely with long-term shareholder value.

Negatives

• The document does not explicitly state any negative aspects.
• The relatively low share prices at which purchases were made (ranging from $0.682 to $0.812) could imply a depressed stock valuation, though this is an inference, not a direct negative stated in the filing.

Risks

• The document does not explicitly mention specific risks to the company's operations or financial health. It is a Schedule 13D filing focused on ownership changes.

Future Outlook

Thomas J. Shaw's Rule 10b5-1 trading plan, established on August 22, 2024, is intended to continue purchasing Retractable Technologies Inc. common stock through November 19, 2025, unless terminated earlier. This indicates a continued intention by a major shareholder to increase or maintain his significant stake in the company.

Industry Context

This filing reflects a significant insider's increasing confidence in Retractable Technologies Inc., which can be a positive signal in the medical device or healthcare supply industry, especially if the company is undergoing strategic shifts or facing market challenges. Such a substantial stake by an individual could influence future corporate strategy or governance, potentially signaling a long-term commitment to the company's direction.

Stakeholder Impact

• Shareholders: Increased confidence due to significant insider buying, potentially signaling undervaluation or strong future performance. The controlling stake by a single individual could influence future strategic decisions.
• Employees: No direct impact mentioned, but a stable and confident major shareholder could contribute to long-term company stability.
• Customers/Suppliers/Creditors: No direct impact mentioned in this filing.

Next Steps

• Continuation of Thomas J. Shaw's Rule 10b5-1 trading plan for purchasing common stock through November 19, 2025, unless terminated earlier.
• Further Form 4 filings will likely be made as additional purchases occur under the 10b5-1 plan.

Key Dates

Recommendation

Keywords

Retractable Technologies Inc., RTI, Thomas J. Shaw, Schedule 13D, Insider Buying, Shareholder Ownership, 10b5-1 Plan, Common Stock, Beneficial Ownership, SEC Filing